Developer docs
API playgroundTry for free, no card

Search company profiles

MediLedger

Full company profile

uuid0006srh

Namestring
MediLedger
Legal namestring
Chronicled, Inc.
Websiteurl
mediledger.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

The MediLedger Project was launched by Chronicled in 2017. It brings together leading Pharmaceutical Manufacturers and Distributors using an advanced and customizable decentralized supply chain management system based on the principles of blockchain. This dynamic system innovates evolving solutions for track and trace regulations, and provides a step function improvement in the overall operation of the supply chain. The MediLedger Project is building an industry-owned permissioned blockchain network for the pharmaceutical sector based on open standards and specifications. Network nodes are set to be distributed among and operated by industry participants and technology providers who serve the industry. This decentralized network is only possible because the MediLedger Project has solved the sensitive issue of data privacy. No business intelligence is shared between partners, but rules are still enforceable due to zero-knowledge transaction verification across the supply chain. This approach can create a vibrant, open development environment and unlock innovative solutions for the pharmaceutical industry beyond the limits of what current technology can offer in the marketplace.

Short descriptiontext

MediLedger brings together expertise in both Pharmaceutical Supply Chain and Blockchain technologies.

Operating statusenum
Closed
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
pharmaceutical supply chain, blockchain traceability, drug anti-counterfeiting, DSCSA compliance, healthcare blockchain
Industry4 codes
PRIMARYIMALAIAJ
Anti-Counterfeit & Track-and-Trace Packaging (Serialization, Security Features)
SECONDARYHLACAKAI
Medication Inventory, Procurement & Supply Chain (Pharmacy)
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYFSADAEAH
Supply Chain & Inventory/Warehouse Receipt Tokenization
Financial & Insurance/Crypto & Digital Assets/Tokenization & Real-World Assets (RWA) Platforms
SECONDARYHLAFALAN
Pharmacovigilance, Medication Safety & Controlled Substance Diversion Monitoring
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
SIC code1 code
  • Security & Commodity Brokers, Dealers, Exchanges & Services6200
Product category
Pharmaceutical Supply Chain Blockchain
Social media profiles1 record
Cost components4 values
Technology or R&D, Personnel, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

MediLedger develops and operates a blockchain-based platform for pharmaceutical supply chain management. The offering focuses on drug traceability, anti-counterfeiting verification, and tamper-evident supply chain records to help pharmaceutical manufacturers meet DSCSA regulatory compliance requirements.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1MediLedger Pharmaceutical Blockchain Platform
CategoryPharmaceutical Supply Chain Software
Description

Blockchain-based platform that provides tamper-evident supply chain records, drug traceability, anti-counterfeiting verification, and DSCSA compliance tooling for pharmaceutical manufacturers and their supply chain partners.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
1Chronicled
TypeDirect peer
Description

Chronicled operates the MediLedger Project, the blockchain pharmaceutical supply chain network directly comparable to MediLedger's offering. It is the closest functional peer in drug traceability and DSCSA compliance.

2TraceLink
TypeDirect peer
Description

TraceLink provides pharmaceutical supply chain serialization, traceability, and DSCSA compliance software to drug manufacturers and distributors, making it a direct competitor for compliance-driven pharma supply chain contracts.

3IBM Blockchain (Healthcare & Pharma)
TypeBroad incumbent
Description

IBM offers enterprise blockchain platforms with pharmaceutical supply chain use cases including drug traceability. It is a broad incumbent that competes for the same pharma blockchain deployments but with a much wider portfolio.

4SAP (Pharmaceutical Supply Chain / blockchain initiatives)
TypeBroad incumbent
Description

SAP provides enterprise pharma supply chain solutions and has pursued blockchain-based serialization initiatives, competing for the same enterprise pharma customers as a broad incumbent with deep existing ERP relationships.

5Optel Group
TypeDirect peer
Description

Optel Group provides traceability, serialization, and anti-counterfeiting solutions for pharmaceutical and other regulated supply chains, making it a direct competitor in drug traceability and supply chain integrity.

6RFXCEL (Antares Vision)
TypeDirect peer
Description

RFXCEL, now part of Antares Vision, offers pharmaceutical serialization, track-and-trace, and supply chain integrity software, directly competing with MediLedger for pharma anti-counterfeiting and compliance contracts.

7OriginTrail
TypeEmerging player
Description

OriginTrail builds blockchain-based supply chain interoperability solutions with pharma and healthcare use cases, overlapping with MediLedger on tamper-evident supply chain data and emerging as an alternative decentralization layer.

8Veeva Systems
TypeBroad incumbent
Description

Veeva Systems provides cloud software for the pharmaceutical and life sciences industry, including supply chain-adjacent and compliance solutions, making it a broad incumbent that touches the same pharma customer base.

9Modum
TypeEmerging player
Description

Modum provides blockchain-based pharmaceutical supply chain monitoring and temperature compliance, addressing the same cold chain integrity and drug traceability problems as MediLedger in a focused, emerging-player capacity.

10FarmaTrust
TypeEmerging player
Description

FarmaTrust applies blockchain and AI to pharmaceutical supply chain integrity, anti-counterfeiting, and regulatory compliance, closely aligning with MediLedger's stated mission around drug authenticity verification.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MediLedger

Pharmaceutical Supply Chain Blockchainmediledger.com

MediLedger brings together expertise in both Pharmaceutical Supply Chain and Blockchain technologies.

What MediLedger does

The MediLedger Project was launched by Chronicled in 2017. It brings together leading Pharmaceutical Manufacturers and Distributors using an advanced and customizable decentralized supply chain management system based on the principles of blockchain. This dynamic system innovates evolving solutions for track and trace regulations, and provides a step function improvement in the overall operation of the supply chain. The MediLedger Project is building an industry-owned permissioned blockchain network for the pharmaceutical sector based on open standards and specifications. Network nodes are set to be distributed among and operated by industry participants and technology providers who serve the industry. This decentralized network is only possible because the MediLedger Project has solved the sensitive issue of data privacy. No business intelligence is shared between partners, but rules are still enforceable due to zero-knowledge transaction verification across the supply chain. This approach can create a vibrant, open development environment and unlock innovative solutions for the pharmaceutical industry beyond the limits of what current technology can offer in the marketplace.

MediLedger firmographics

Firmographics
Name
MediLedger
Legal name
Chronicled, Inc.
Website
https://mediledger.com
Company type
Private
Founded year
2017
Operating status
Closed
Headcount range
11–50 employees
Short description
MediLedger brings together expertise in both Pharmaceutical Supply Chain and Blockchain technologies.
Ownership category
akta.pro rank

MediLedger industry classification

Industry
Product category
Pharmaceutical Supply Chain Blockchain
SIC
Security & Commodity Brokers, Dealers, Exchanges & Services (6200)
akta.pro industry
PRIMARYIMALAIAJ
Anti-Counterfeit & Track-and-Trace Packaging (Serialization, Security Features)
SECONDARYHLACAKAI
Medication Inventory, Procurement & Supply Chain (Pharmacy)
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYFSADAEAH
Supply Chain & Inventory/Warehouse Receipt Tokenization
Financial & Insurance/Crypto & Digital Assets/Tokenization & Real-World Assets (RWA) Platforms
SECONDARYHLAFALAN
Pharmacovigilance, Medication Safety & Controlled Substance Diversion Monitoring
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services

Keywords

  • Pharmaceutical supply chain
  • Blockchain traceability
  • Drug anti-counterfeiting
  • DSCSA compliance
  • Healthcare blockchain

Where MediLedger is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Markets served

MediLedger business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations

MediLedger product offering

Product offering

Core offering

MediLedger develops and operates a blockchain-based platform for pharmaceutical supply chain management. The offering focuses on drug traceability, anti-counterfeiting verification, and tamper-evident supply chain records to help pharmaceutical manufacturers meet DSCSA regulatory compliance requirements.

Differentiator

Problem solved

Functional benefit

Products and services

  • MediLedger Pharmaceutical Blockchain Platform Blockchain-based platform that provides tamper-evident supply chain records, drug traceability, anti-counterfeiting verification, and DSCSA compliance tooling for pharmaceutical manufacturers and their supply chain partners.

Companies that use MediLedger

Customer profile

Segments3 records

Ideal customer profiles3 records

MediLedger technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

MediLedger partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves1 record

Expansion highlights2 records

MediLedger competitors and assessment

Company assessment

Direct peers

  • Chronicled: Chronicled operates the MediLedger Project, the blockchain pharmaceutical supply chain network directly comparable to MediLedger's offering. It is the closest functional peer in drug traceability and DSCSA compliance.
  • TraceLink: TraceLink provides pharmaceutical supply chain serialization, traceability, and DSCSA compliance software to drug manufacturers and distributors, making it a direct competitor for compliance-driven pharma supply chain contracts.
  • Optel Group: Optel Group provides traceability, serialization, and anti-counterfeiting solutions for pharmaceutical and other regulated supply chains, making it a direct competitor in drug traceability and supply chain integrity.
  • RFXCEL (Antares Vision): RFXCEL, now part of Antares Vision, offers pharmaceutical serialization, track-and-trace, and supply chain integrity software, directly competing with MediLedger for pharma anti-counterfeiting and compliance contracts.

Broad incumbents

  • IBM Blockchain (Healthcare & Pharma): IBM offers enterprise blockchain platforms with pharmaceutical supply chain use cases including drug traceability. It is a broad incumbent that competes for the same pharma blockchain deployments but with a much wider portfolio.
  • SAP (Pharmaceutical Supply Chain / blockchain initiatives): SAP provides enterprise pharma supply chain solutions and has pursued blockchain-based serialization initiatives, competing for the same enterprise pharma customers as a broad incumbent with deep existing ERP relationships.
  • Veeva Systems: Veeva Systems provides cloud software for the pharmaceutical and life sciences industry, including supply chain-adjacent and compliance solutions, making it a broad incumbent that touches the same pharma customer base.

Emerging players

  • OriginTrail: OriginTrail builds blockchain-based supply chain interoperability solutions with pharma and healthcare use cases, overlapping with MediLedger on tamper-evident supply chain data and emerging as an alternative decentralization layer.
  • Modum: Modum provides blockchain-based pharmaceutical supply chain monitoring and temperature compliance, addressing the same cold chain integrity and drug traceability problems as MediLedger in a focused, emerging-player capacity.
  • FarmaTrust: FarmaTrust applies blockchain and AI to pharmaceutical supply chain integrity, anti-counterfeiting, and regulatory compliance, closely aligning with MediLedger's stated mission around drug authenticity verification.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights4 records

Customer concentration

MediLedger social profiles

Digital presence

MediLedger financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MediLedger leadership team

Management profile

Number of profiles

Profiles2 records

MediLedger funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MediLedger M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MediLedger

What does MediLedger do?

MediLedger develops and operates a blockchain-based platform for pharmaceutical supply chain management. The offering focuses on drug traceability, anti-counterfeiting verification, and tamper-evident supply chain records to help pharmaceutical manufacturers meet DSCSA regulatory compliance requirements.

Is MediLedger a public or private company?

MediLedger is a private company. It is classified as unknown and is currently closed.

When was MediLedger founded?

MediLedger was founded in 2017. It employs 11 to 50 people.

Where is MediLedger based?

MediLedger is headquartered in San Francisco, United States, in the North America region.

Who are MediLedger's main competitors?

Direct peers on record are Chronicled, TraceLink, Optel Group and RFXCEL (Antares Vision). Broad incumbents are IBM Blockchain (Healthcare & Pharma), SAP (Pharmaceutical Supply Chain / blockchain initiatives) and Veeva Systems. Emerging players are OriginTrail, Modum and FarmaTrust.

Does MediLedger have an API?

No public API is recorded for MediLedger.

What industry is MediLedger in?

MediLedger's product category is Pharmaceutical Supply Chain Blockchain. Its primary akta.pro industry code is IMALAIAJ, Anti-Counterfeit & Track-and-Trace Packaging (Serialization, Security Features), with a secondary code of HLACAKAI, Medication Inventory, Procurement & Supply Chain (Pharmacy). Its SIC code is 6200.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PixelPlex6 Blockchain Use Cases in Healthcare: A Detailed OverviewThe article outlines six key blockchain applications in healthcare, including patient record management, drug supply chain tracking, credential verification, genomic research, clinical trial security, and telemedicine. It cites market projections estimating the sector's value to grow from $0.76 billion in 2022 to $14.25 billion by 2032. The piece highlights specific companies such as BurstIQ, MediLedger, Nebula Genomics, and MedX as examples of firms implementing these decentralized solutions.PharmiWeb.comOSF HealthCare Joins MediLedger Network to Enhance Pricing Accuracy and Contract ManagementOSF HealthCare joined the MediLedger network on May 14, 2024, to deploy technology for pricing accuracy and contract management across its pharmacy sites. The system uses a four-way matching mechanism among GPOs, manufacturers, and distributors to ensure consistent pricing and reduce administrative effort.GlobalrphBlockchain To Transform The Pharmaceutical Supply Chains: Drug Traceability and AuthenticationBlockchain technology is being adopted by pharmaceutical companies to create transparent, tamper-proof records that combat counterfeit drugs and enhance patient safety. Key industry participants such as Mediledger and Alibaba Group's Ali Health have implemented these systems to verify drug authenticity and streamline supply chain processes.NewswireVinod Lakhani Appointed as New CEO of Chronicled, the Company Behind the MediLedger Blockchain NetworkChronicled appointed Vinod Lakhani as CEO, succeeding Susanne Somerville, who will remain an advisor. Lakhani previously served as COO and CPO at Chronicled. The company will focus on scaling MediLedger's blockchain network for life sciences and medical-surgical industries.ChekkitappHow Can Blockchain Help Pharma Supply Chain Traceability?This article is an informational explainer on how blockchain technology improves pharmaceutical supply chain traceability through advantages in resilience, security, and efficiency compared to traditional centralized systems. It cites Deloitte research showing blockchain can reduce product tracking time by up to 50% and Accenture findings of up to 30% cost reduction. The article references several blockchain implementations in the pharmaceutical industry, including Chekkit's Pharma Ledger integrated with GS1 EPCIS standards, IBM's partnership with Walgreens and KPMG for drug tracking, and Mediledger's piloted traceability system.PR NewswireParity Technologies and MediLedger Network Announce Partnership to Deliver Blockchain-Powered Solutions to the Life Sciences IndustryChronicled, the technology company behind MediLedger Network, has entered into a partnership with Parity Technologies to deliver blockchain-powered solutions to the Life Sciences industry, leveraging Substrate and Polkadot to improve supply chain integrity and efficiency. Over 77 pharmaceutical firms participate in MediLedger, including 9 of the top 10 manufacturers, and the partnership aims to reduce industry error rates from approximately 4% to around 0.1% in chargeback disputes, pricing errors, and cash flow inefficiencies. The collaboration enables MediLedger to interoperate with public blockchains, creating hybrid use cases and tokenization opportunities within Life Sciences.Ledger InsightsMediLedger creator Chronicled to collaborate with Deloitte to fight counterfeit COVID-19 drugs - Ledger Insights - blockchain for enterpriseChronicled, the firm behind MediLedger, announced a collaboration with Deloitte to address counterfeit drugs in supply chains. The blockchain-based solution stores drug data to compare returned drugs against manufacturer records, responding to the U.S. Drug Supply Chain Security Act's traceability deadlines.PR NewswireLeaders from 24 companies in the US Pharmaceutical Supply Chain collaborate to submit the MediLedger DSCSA Pilot Project Final Report to the FDA, proposing blockchain for an interoperable track and trThe MediLedger Project, a working group of 24 pharmaceutical manufacturers, distributors, retail chains, and logistics providers, submitted its final DSCSA Pilot Project Report to the FDA in February 2020, demonstrating how blockchain technology can meet the 2023 Drug Supply Chain and Security Act requirements for an interoperable track and trace system. The report shows that a decentralized blockchain platform using zero-knowledge proofs can validate drug authenticity and provenance while keeping proprietary data under each company's control. Participants included AmerisourceBergen, Pfizer, Genentech, McKesson, Walgreens, Walmart, and 19 other companies, with Chronicled providing the underlying MediLedger blockchain network.BeckershospitalreviewViewpoint: How blockchain is benefiting healthcare - Becker's Hospital Review | Healthcare News & AnalysisBlockchain is being used in healthcare to securely maintain and distribute patient data, according to Garratt Hasenstab. MediLedger is testing blockchain to trace prescription drugs from manufacturers to patients, and Orderly Health and BurstIQ are developing a blockchain-based provider data management platform.PR NewswireMediLedger's Blockchain Pilot to Assist Drug Supply Chain Stakeholders in Developing an Interoperable Track & Trace System for the US DSCSA Regulations Has Kicked OffMediLedger announced its participation in the FDA Pilot Project Program to develop an interoperable electronic tracking system for prescription drugs under the DSCSA, effective 2023. The pilot, coordinated by Chronicled, involves over 20 industry stakeholders including Pfizer, Genentech, and McKesson, and will conclude by November 2019.